Pierre Lantéri

Pierre Lantéri

Auto-generated profile, based on publicly available information

Pierre Lantéri

Institut des Sciences Analytiques UMR 5280 CNRS Université de Lyon Université Claude Bernard Lyon 1 5 rue de la Doua 69100 Villeurbanne France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CBC. Bordes
C. Bordes
VFV. Fréville
V. Fréville
ERE. Ruffin
E. Ruffin
PMP. Marote
P. Marote
JGJ.Y. Gauvrit
J.Y. Gauvrit
PLP. Lantéri
P. Lantéri

1 November 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
RSRomain Simon
Romain Simon
MGMarion Girod
Marion Girod
CFCatherine Fonbonne
Catherine Fonbonne
ASArnaud Salvador
Arnaud Salvador
YCYohann CLEMENT
Yohann CLEMENT
JLJérôme Lemoine
Jérôme Lemoine
Allelic polymorphism of the apolipoprotein E (ApoE) gene (ApoE ε2, ApoE ε3 and ApoE ε4 alleles) gives rise to three protein isoforms (ApoE2, ApoE3 and ApoE4) that differ by 1 or 2 amino acids. Inheritance of the ApoE ε4 allele is a risk factor for developing Alzheimer9s disease (AD). The potential diagnostic value of ApoE protein levels in biological fluids (i.e. cerebrospinal fluid, plasma and serum) for distinguishing between AD patients and healthy elderly subjects is subject to great controversy. Although a recent study reported subnormal total ApoE and ApoE4 levels in the plasma of AD patients, other studies have found normal or even elevated protein levels (versus controls). Because all previously reported assays were based on immunoenzymatic techniques, we decided to develop an orthogonal assay based on targeted mass spectrometry by tracking (i) a proteotypic peptide common to all ApoE isoforms and (ii) a peptide that is specific for the ε4 allele. After trypsin digestion, the ApoE4-specific peptide contains an oxidation-prone methionine residue. The endogenous methionine oxidation level was evaluated in a small cohort (n = 68) of heterozygous ε3ε4 carriers containing both healthy controls and AD patients. As expected, the proportion of oxidized residues varied from 0 to 10%, with an average of 5%. We therefore developed a standardized strategy for the unbiased, absolute quantification of ApoE4, based on performic acid oxidization of methionine. Once the sample workflow had been thoroughly validated, it was applied to the concomitant quantification of total ApoE and ApoE4 isoform in a large case-control study (n = 669). The final measurements were consistent with most previously reported ApoE concentration values and confirm the influence of the different alleles on the protein expression level. Our results illustrate (i) the reliability of selected reaction monitoring-based assays and (ii) the value of the oxidization step for unbiased monitoring of methionine-containing proteotypic peptides. Furthermore, a statistical analysis indicated that neither total ApoE and ApoE4 levels nor the ApoE/ApoE4 ratio correlated with the diagnosis of AD. These findings reinforce the conclusions of previous studies in which plasma ApoE levels had no obvious clinical significance.

15 February 2008 in Talanta
Verified
Journal Article
Closed access
APAnne Piram
Anne Piram
ASArnaud Salvador
Arnaud Salvador
JGJean-Yves Gauvrit
Jean-Yves Gauvrit
PLPierre Lanteri
Pierre Lanteri
RFRené Faure
René Faure

1 December 2011 in Forensic Science International
Verified
Journal Article
Closed access
JBJulien Boccard
Julien Boccard
FBFlavia Badoud
Flavia Badoud
EGElia Grata
Elia Grata
SOSamia Ouertani
Samia Ouertani
MHMohamed Hanafi
Mohamed Hanafi
SRSerge Rudaz
Serge Rudaz

11 September 2001 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
SRSerge Rudaz
Serge Rudaz
SCSamir Cherkaoui
Samir Cherkaoui
JGJean-Yves Gauvrit
Jean-Yves Gauvrit
PLPierre Lantéri
Pierre Lantéri
JVJean-Luc Veuthey
Jean-Luc Veuthey

1 January 1997 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
EVEmmanuel Varesio
Emmanuel Varesio
JGJean‐Yves Gauvrit
Jean‐Yves Gauvrit
RLRémi Longeray
Rémi Longeray
PLPierre Lantéri
Pierre Lantéri
JVJean‐Luc Veuthey
Jean‐Luc Veuthey